
Glencore will pay US$9.85 million to resolve antitrust claims over its alleged scheme to fix the price of zinc by rigging warehouse storage queues and manipulating the complex relationship between the physical and financial metals markets, according to a federal court filing in Manhattan.
The proposed settlement, which requires the approval of Judge Paul A. Engelmayer, would conclude class action litigation against Glencore in the US District Court for the Southern District of New York, where the case has been advancing in fits and starts since 2014.
Zinc purchasers accused U.S.-based Glencore Ltd and Pacorini Metals USA Inc of conspiring from September 2010 to February 2016 to ensure long queues for physical zinc, or Special High Grade zinc, at warehouses licensed by the London Metal Exchange.
They said this allowed Glencore to receive higher storage fees and command increased premiums when selling zinc.
Zinc is used to coat steel to protect against corrosion and is also used in batteries, castings and alloys such as brass.
The U.S. Geological Survey said zinc accounted for 7% of the country’s $28.1 billion of metal mine production in 2019, trailing only gold, copper and iron ore.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas